Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Assessment of p53 and ATM Functionality in Chronic Lymphocytic Leukemia By Multiplex Ligation-Dependent Probe Amplification

Doreen te Raa, Perry Moerland, Alexander Leeksma, Ingrid Derks, Martin Loden, Veronika Navrkalova, Martin Trbusek, PhD, Dieuwertje Luijks, Thorsten Zenz, MD, Anna Skowronska, PhD, Tatjana Stankovic, Mels Hoogendoorn, MD PhD, Marinus H. J. van Oers, Eric Eldering, PhD, Arnon P. Kater, MD PhD

Blood (2015) 126 (23): 2918.

https://doi.org/10.1182/blood.V126.23.2918.2918

Published: 2015

Journal Articles

Factor VII-Activating Protease Is a Regulator of Histone Cytotoxicity

Gerben Marsman, Helen von Richthofen, Ingrid Bulder, Lucien Aarden, Marinus H. J. van Oers, Brenda M. Luken, Sacha Zeerleder, MD PhD

Blood (2015) 126 (23): 1005.

https://doi.org/10.1182/blood.V126.23.1005.1005

Published: 2015

Journal Articles

Donor-Derived B Cells Produce Potent AML-Specific Antibodies That Recognize Novel Tumor-Specific Antigens and Mediate Graft-Versus-Leukemia Immunity

Marijn Aletta Gillissen, MD, Martijn Kedde, Etsuko Yasuda, PhD, Sophie E. Levie, Arjen Q. Bakker, Yvonne B. Claassen, Martino Bohne, Dave Speijer, PhD, Daisy I. Picavet, Jan Stap, Marinus H. J. van Oers, Tim Beaumont, PhD, Pauline M. van Helden, PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD

Blood (2015) 126 (23): 3146.

https://doi.org/10.1182/blood.V126.23.3146.3146

Published: 2015

Journal Articles

Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease

J. Marius Munneke, Andreas T. Björklund, Jenny M. Mjösberg, Karin Garming-Legert, Jochem H. Bernink, Bianca Blom, Cynthia Huisman, Marinus H. J. van Oers, Hergen Spits, Karl-Johan Malmberg, Mette D. Hazenberg

Blood (2014) 124 (5): 812–821.

https://doi.org/10.1182/blood-2013-11-536888

Published: 2014

Includes: Supplemental data

Journal Articles

Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL

Christian H. Geisler, Mars B. van t’ Veer, Jesper Jurlander, Jan Walewski, Geir Tjønnfjord, Maija Itälä Remes, Eva Kimby, Tomas Kozak, Aaron Polliack, Ka Lung Wu, Shulamiet Wittebol, Martine C. J. Abrahamse-Testroote, Jeanette Doorduijn, Wendimagegn Ghidey Alemayehu, Marinus H. J. van Oers

Blood (2014) 123 (21): 3255–3262.

https://doi.org/10.1182/blood-2014-01-547737

Published: 2014

Includes: Supplemental data

Journal Articles

CMV-specific CD8 + T-cell function is not impaired in chronic lymphocytic leukemia

G. Doreen te Raa, Maria Fernanda Pascutti, Juan J. García-Vallejo, Emilie Reinen, Ester B. M. Remmerswaal, Ineke J. M. ten Berge, René A. W. van Lier, Eric Eldering, Marinus H. J. van Oers, Sanne H. Tonino, Arnon P. Kater

Blood (2014) 123 (5): 717–724.

https://doi.org/10.1182/blood-2013-08-518183

Published: 2014

Includes: Supplemental data

Journal Articles

Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model

Valeria Lascano, Marco Guadagnoli, Jan G. Schot, Dieuwertje M. Luijks, Jeroen E. J. Guikema, Katherine Cameron, Michael Hahne, Steven Pals, Erik Slinger, Thomas J. Kipps, Marinus H. J. van Oers, Eric Eldering, Jan Paul Medema, Arnon P. Kater

Blood (2013) 122 (24): 3960–3963.

https://doi.org/10.1182/blood-2013-04-497693

Published: 2013

Includes: Supplemental data

Journal Articles

IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells

Maria Fernanda Pascutti, Margot Jak, Jacqueline M. Tromp, Ingrid A. M. Derks, Ester B. M. Remmerswaal, Rachel Thijssen, Martijn H. A. van Attekum, Gregor G. van Bochove, Dieuwertje M. Luijks, Steven T. Pals, René A. W. van Lier, Arnon P. Kater, Marinus H. J. van Oers, Eric Eldering

Blood (2013) 122 (17): 3010–3019.

https://doi.org/10.1182/blood-2012-11-467670

Published: 2013

Includes: Supplemental data

Journal Articles

C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia

Diana Wouters, Femke Stephan, Paul Strengers, Masja de Haas, Conny Brouwer, Anton Hagenbeek, Marinus H. J. van Oers, Sacha Zeerleder

Blood (2013) 121 (7): 1242–1244.

https://doi.org/10.1182/blood-2012-11-467209

Published: 2013

Journal Articles

Assessment of p53 Functionality in Chronic Lymphocytic Leukemia by Different Assays; An Eric-Wide Approach.

Doreen te Raa, MD, Jitka Malcikova, Dr, PhD, Marek Mraz, Sarka Pospisilova, PhD, Magali Le Garff-Tavernier, Helene Merle-Beral, MD, PhD, Tatjana Stankovic, MD., PhD, Marinus H. J. van Oers, MD PhD, Eric Eldering, PhD, Stephan Stilgenbauer, MD, Thorsten Zenz, MD, PhD, Arnon P. Kater, MD PhD

Blood (2012) 120 (21): 2872.

https://doi.org/10.1182/blood.V120.21.2872.2872

Published: 2012

Journal Articles

CD20 antibodies: type II to tango?

Marinus H. J. van Oers

Blood (2012) 119 (22): 5061–5063.

https://doi.org/10.1182/blood-2012-04-420711

Published: 2012

Journal Articles

R-DHAP Immuno-Chemotherapy Is An Effective Remission-Induction Treatment for Fludarabine Refractory CLL Patients and Allows the Majority to Proceed to Allogeneic Stem Cell Transplantation. Results of the Planned Interim Analysis of the Dutch-Belgian Prospective Multicenter HOVON88 Trial,

Michel Van Gelder, Wendim Ghidey, Martine ED Chamuleau, MD, Jan J Cornelissen, MD, PhD, Ka Lung Wu, MD, PhD, Mels Hoogendoorn, S. M. G. J. Daenen, Eefke Petersen, MD, Marinus H. J. van Oers

Blood (2011) 118 (21): 3911.

https://doi.org/10.1182/blood.V118.21.3911.3911

Published: 2011

Journal Articles

CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101

Margot Jak, Gregor G. W. van Bochove, Eric A. Reits, Wouter W. Kallemeijn, Jacqueline M. Tromp, Pablo Umana, Christian Klein, Rene A. W. van Lier, Marinus H. J. van Oers, Eric Eldering

Blood (2011) 118 (19): 5178–5188.

https://doi.org/10.1182/blood-2011-01-331702

Published: 2011

Includes: Supplemental data

Journal Articles

ROS-Mediated Upregulation of Noxa Overcomes Drug-Resistance Due to P53-Dysfunction in Chronic Lymphocytic Leukemia.

Sanne H. Tonino, Jacoline M van Laar, Marinus H. J. van Oers, Jean Y.J. Wang, PhD, Eric Eldering, Arnon P. Kater, MD, PhD

Blood (2009) 114 (22): 2382.

https://doi.org/10.1182/blood.V114.22.2382.2382

Published: 2009

Journal Articles

R-DHAP Is Effective in Fludarabine-Refractory CLL, Possibly Via Upregulation of Pro-Apoptotic P73.

Sanne H. Tonino, Michel Van Gelder, MD, PhD, Eric Eldering, Marinus H. J. van Oers, Arnon P. Kater, MD, PhD

Blood (2009) 114 (22): 3449.

https://doi.org/10.1182/blood.V114.22.3449.3449

Published: 2009

Journal Articles

miR-34a as part of the resistance network in chronic lymphocytic leukemia

Thorsten Zenz, Julia Mohr, Eric Eldering, Arnon P. Kater, Andreas Bühler, Dirk Kienle, Dirk Winkler, Jan Dürig, Marinus H. J. van Oers, Daniel Mertens, Hartmut Döhner, Stephan Stilgenbauer

Blood (2009) 113 (16): 3801–3808.

https://doi.org/10.1182/blood-2008-08-172254

Published: 2009

Includes: Supplemental data

Journal Articles

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison

Blood (2009) 113 (6): 1375–1382.

https://doi.org/10.1182/blood-2008-07-168625

Published: 2009

Includes: Supplemental data

Journal Articles

c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches

Delfine Y. H. Hallaert, Annelieke Jaspers, Carel J. van Noesel, Marinus H. J. van Oers, Arnon P. Kater, Eric Eldering

Blood (2008) 112 (13): 5141–5149.

https://doi.org/10.1182/blood-2008-03-146704

Published: 2008

Includes: Supplemental data

Journal Articles

Array CGH Analysis of Chronic Lymphocytic Leukemia Reveals Frequent Cryptic Monoallelic and Biallelic Deletions of Chromosome 22q11.

William D. McClain, Shelly R. Gunn, Aswani R. Bolla, Lynn L. Barron, Mercedes E. Gorre, David W. Bahler, Clemens H. M. Mellink, Marinus H. J. van Oers, Michael J. Keating, Alessandra Ferrajoli, Kevin R. Coombes, Lynne V Abruzzo, MD, PhD, Ryan S. Robetorye

Blood (2008) 112 (11): 1050.

https://doi.org/10.1182/blood.V112.11.1050.1050

Published: 2008

Journal Articles

Enhanced Formation and Survival of Regulatory T Cells in CLL.

Margot Jak, Rogier Mous, Ester BM Remmerswaal, René Spijker, Annelieke Jaspers, Adriana Yagüe, Eric Eldering, René A.W. van Lier, Marinus H. J. van Oers

Blood (2008) 112 (11): 1065.

https://doi.org/10.1182/blood.V112.11.1065.1065

Published: 2008

NARROW

Assessment of p53 and ATM Functionality in Chronic Lymphocytic Leukemia By Multiplex Ligation-Dependent Probe Amplification

Factor VII-Activating Protease Is a Regulator of Histone Cytotoxicity

Donor-Derived B Cells Produce Potent AML-Specific Antibodies That Recognize Novel Tumor-Specific Antigens and Mediate Graft-Versus-Leukemia Immunity

Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease

Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL

CMV-specific CD8 + T-cell function is not impaired in chronic lymphocytic leukemia

Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model

IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells

C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia

Assessment of p53 Functionality in Chronic Lymphocytic Leukemia by Different Assays; An Eric-Wide Approach.

CD20 antibodies: type II to tango?

R-DHAP Immuno-Chemotherapy Is An Effective Remission-Induction Treatment for Fludarabine Refractory CLL Patients and Allows the Majority to Proceed to Allogeneic Stem Cell Transplantation. Results of the Planned Interim Analysis of the Dutch-Belgian Prospective Multicenter HOVON88 Trial,

CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101

ROS-Mediated Upregulation of Noxa Overcomes Drug-Resistance Due to P53-Dysfunction in Chronic Lymphocytic Leukemia.

R-DHAP Is Effective in Fludarabine-Refractory CLL, Possibly Via Upregulation of Pro-Apoptotic P73.

miR-34a as part of the resistance network in chronic lymphocytic leukemia

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison

c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches

Array CGH Analysis of Chronic Lymphocytic Leukemia Reveals Frequent Cryptic Monoallelic and Biallelic Deletions of Chromosome 22q11.

Enhanced Formation and Survival of Regulatory T Cells in CLL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only